Literature DB >> 7512094

Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies.

A Ripalti1, Q Ruan, M C Boccuni, F Campanini, G Bergamini, M P Landini.   

Abstract

We have previously shown that single linear epitopes of the major human cytomegalovirus (HCMV) antigens, expressed as fusion proteins or synthesized as oligopeptides, can be valuable diagnostic material in the serology of HCMV infection (M. P. Landini, M. X. Guan, G. Jahn, W. Lindenmaier, M. Mach, A. Ripalti, A. Necker, T. Lazzarotto, and B. Plachter, J. Clin. Microbiol. 28:1375-1379, 1990; M. P. Landini, T. Lazzarotto, A. Ripalti, M. X. Guan, and M. La Placa, J. Clin. Microbiol. 27:2324-2327, 1989; A. Ripalti, M. P. Landini, E. S. Mocarski, and M. La Placa, J. Gen. Virol. 70:1247-1251, 1989). In this work we addressed the question of whether the expression of more than one linear epitope on a single fusion protein could increase the reactivity of genetically engineered antigenic material with human antibody. To answer this question we fused sequences expressing two different epitopes contained in the basic phosphoprotein of 150 kDa encoded by UL32 (M. S. Chee, A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, T. Cerny, T. Hornsel, C. A. Hutchinson, T. Kouzarides, J. A. Martignetti, and B. G. Barrell, Curr. Top. Microbiol. Immunol. 154:125-169, 1990; G. Jahn, T. Kouzarides, M. Mach, B.-C. Scholl, B. Plachter, B. Traupe, E. Preddie, S. C. Satchwell, B. Fleckenstein, and B. G. Barrell, J. Virol. 61:1358-1367, 1987), ppUL32, which was repeatedly shown to be the strongest immunogen present in the viral particle. We also made fusions with sequences expressing a single epitope repeated once, twice, or three times. The different fusion proteins were tested with HCMV-positive human sera. We found that fusion proteins expressing different epitopes together were recognized by a larger number of serum specimens and with more intense reactions in Western blot (immunoblot) experiments. We also found evidence that expression on the same polypeptide of the two distinct epitopes produced a stronger antigen than the mere addition of two fusion proteins which each carried one copy of one of these epitopes. Furthermore, we found that while the same epitope expressed two or three times on the same fusion protein was not better recognized by immunoglobulin G than the single epitope, immunoglobulin M reactivities to the double and triple epitopes were enhanced.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512094      PMCID: PMC263036          DOI: 10.1128/jcm.32.2.358-363.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Large-scale screening of human sera with cytomegalovirus recombinant antigens.

Authors:  M P Landini; M X Guan; G Jahn; W Lindenmaier; M Mach; A Ripalti; A Necker; T Lazzarotto; B Plachter
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

2.  Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides.

Authors:  J Novák; P Sova; V Krchnák; E Hamsíková; H Závadová; J Roubal
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

Review 3.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family.

Authors:  E S Mocarski; L Pereira; N Michael
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  Cloning of the human cytomegalovirus genome as endonuclease XbaI fragments.

Authors:  D R Thomsen; M F Stinski
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

6.  The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties.

Authors:  G Jahn; B C Scholl; B Traupe; B Fleckenstein
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

7.  Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus.

Authors:  G Jahn; T Kouzarides; M Mach; B C Scholl; B Plachter; B Traupe; E Preddie; S C Satchwell; B Fleckenstein; B G Barrell
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

9.  Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis.

Authors:  A Ripalti; M P Landini; E S Mocarski; M La Placa
Journal:  J Gen Virol       Date:  1989-05       Impact factor: 3.891

10.  Prokaryotic expression of immunogenic polypeptides of the large phosphoprotein (pp150) of human cytomegalovirus.

Authors:  B C Scholl; J Von Hintzenstern; B Borisch; B Traupe; M Bröker; G Jahn
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

View more
  6 in total

1.  The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens.

Authors:  G T Maine; T Lazzarotto; L E Chovan; R Flanders; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

2.  Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins.

Authors:  L D Cranmer; C L Clark; C S Morello; H E Farrell; W D Rawlinson; D H Spector
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.

Authors:  W G Starkey; J Newcombe; K M Corbett; K M Liu; P G Sanders; J M Best
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

Review 4.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

5.  Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.

Authors:  M P Landini; T Lazzarotto; G T Maine; A Ripalti; R Flanders
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

6.  Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene.

Authors:  A Ripalti; M C Boccuni; F Campanini; M P Landini
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.